Frontlight ResearchEarly access
Trial site
AZ Groeninge Campus Kennedylaan
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Obesity3 trials
- Type 2 diabetes2 trials
- Ulcerative colitis2 trials
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- and 3 more
- Phase
- Phase 39 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting3 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Bayer2 trials
- Incyte Corporation1 trial
- InDex Pharmaceuticals1 trial
- Stemline Therapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Metastatic breast cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Terminated
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026